• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Growth in Cryptocurrency VC Investments in Q1: Overview by Galaxy Report

user avatar

by Giorgi Kostiuk

2 years ago


Galaxy Digital, a renowned blockchain investment firm, recently published a detailed report on the status of venture capital (VC) investments in the cryptocurrency sector. The report highlighted a substantial increase in investments during the first quarter, with close to $2.5 billion spread across 603 deals. This growth was significant compared to the previous quarter.

The report unveiled a 29% surge in the dollar value and an impressive 68% rise in the number of deals compared to the previous quarter. It was the first time in three quarters that both measures showed growth simultaneously. Despite the positive growth seen, Galaxy emphasized the need to observe future quarters to determine if this trend can be maintained.

Factors Affecting VC Investment in Cryptocurrency

Galaxy mentioned that the rise in invested capital was modest due to various factors that could potentially restrict VC investment in the cryptocurrency sector. These factors include a high-interest environment, the failures of cryptocurrency companies in 2022, and a shortage of later-stage companies capable of receiving significant investments.

Furthermore, the emergence of Bitcoin Exchange-Traded Funds (ETFs) might divert funding and attention away from startups. Nevertheless, Galaxy acknowledged that ETFs and startups cater to different investment preferences.

Three Primary Categories

Galaxy's study highlighted the three main categories in the crypto sector that attracted the most funding in the first quarter, although it acknowledged the breadth of these categories. Infrastructure companies, which include staking, platform tools, and sequencing services, secured 24% of the total funds raised. Web3 companies received 21% of the investment, while trading firms obtained 17%. These categories also dominated deal counts, with infrastructure firms making up 24% of deals, web3 companies 15%, and trading firms 12%.

DeFi companies displayed a distinct variation, raising 6% of capital but accounting for 10% of all deals. Galaxy also pointed out substantial investments in Bitcoin Layer-2 projects, primarily driven by Ordinals and related standards. However, the Layer 2 category only attracted 7% of capital and 6% of deals.

Prevailing Trend Led by Early-Stage Crypto Firms

The report from Galaxy outlined the significance of early-stage deals in the first quarter, with companies falling into this category securing 80% of the funding. The majority of investment activity centered around startups established in the past few years, particularly those founded between 2021 and 2023. This trend is attributed to the availability of substantial funding for early-stage companies from crypto-specific funds, while larger generalist VC firms have either departed from the crypto sector or decreased their involvement.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Lighter Anticipated for Zero-Fee Trading Launch

chest

Lighter is preparing for its launch with a unique offering of zero fees on both perpetual and spot trading, backed by Robinhood.

user avatarTenzin Dorje

Beyond Tech Innovates Bitcoin DeFi with Unique Routing Layer

chest

Beyond Tech is developing a routing layer for Bitcoin DeFi, powered by LayerZero, allowing yield settlement from Base and Solana directly onto Bitcoin as BRC20 assets.

user avatarDiego Alvarez

Talus Network Secures Major Funding for Expansion

chest

Talus Network has raised $10 million in funding, positioning itself for a significant market rollout.

user avatarElias Mukuru

Monad Shows Enormous Growth Potential

chest

Monad is processing millions of transactions daily while operating at a fraction of its capacity, indicating significant growth potential.

user avatarMohamed Farouk

PIONEER Trial Shows Promising Results for Pociredir in Sickle Cell Disease

chest

The Phase 1b PIONEER trial of pociredir for sickle cell disease showed a 99% increase in fetal hemoglobin levels and 67% of patients reported no vasoocclusive crises, indicating promising results.

user avatarBayarjavkhlan Ganbaatar

Fulcrum Therapeutics Stock Surges 48% Following Positive Trial Results

chest

Fulcrum Therapeutics, Inc. saw a significant premarket surge of 48.20% after announcing positive results from its Phase 1b PIONEER trial for pociredir, a treatment for sickle cell disease.

user avatarAisha Farooq

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.